Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Analysis of Population Pharmacokinetic Data01:12

Analysis of Population Pharmacokinetic Data

957
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
957
Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions01:15

Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions

88
PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure...
88
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

104
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
104
Dosage Regimens: Partial Pharmacokinetic Parameters01:01

Dosage Regimens: Partial Pharmacokinetic Parameters

356
It is not uncommon for complete drug pharmacokinetic profiles to remain elusive in pharmacokinetics. This necessitates certain educated assumptions by pharmacokineticists to determine appropriate dosage regimens without comprehensive pharmacokinetic data from animal or human studies. One prevalent assumption is setting the bioavailability factor, denoted as F, to 1 or 100%. This assumption caters to the scenario where a drug doesn't achieve full systemic absorption, resulting in the patient...
356
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

587
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
587
Drug Toxicity: Risk factors01:24

Drug Toxicity: Risk factors

214
Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...
214

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Evaluation of a pharmacist-led medication review and optimisation service in the management of cardiometabolic disease.

European journal of hospital pharmacy : science and practice·2026
Same author

Systematic review of independent pharmacist prescribing for the treatment of cardiometabolic factors in chronic non-communicable diseases.

European journal of hospital pharmacy : science and practice·2026
Same author

iSIMPATHY: a multinational pre-post non-randomised intervention study transforming medication review.

BMJ open·2025
Same author

Addressing potentially inappropriate prescribing in care homes: regional evaluation of a pharmacist-led model in Northern Ireland.

International journal of clinical pharmacy·2025
Same author

Service development project to pilot a digital technology innovation for video direct observation of therapy in adult patients with asthma.

BMJ open quality·2024
Same author

Medication Adherence in Children with Asthma.

Patient preference and adherence·2024

Related Experiment Video

Updated: Apr 19, 2026

Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack
07:31

Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack

Published on: May 15, 2020

8.3K

Enhanced clinical pharmacy service targeting tools: risk-predictive algorithms.

Feras W D El Hajji1, Claire Scullin, Michael G Scott

  • 1Clinical and Practice Research Group, School of Pharmacy, Queen's University Belfast, Belfast, UK.

Journal of Evaluation in Clinical Practice
|December 16, 2014
PubMed
Summary

Predictive algorithms using clinical pharmacy and hospital data accurately forecast patient mortality and readmission risks. Increased clinical pharmacy staffing is linked to reduced risk-adjusted mortality, optimizing patient care.

Keywords:
RAMIage-adjusted co-morbidityclinical pharmacy targetingoptimize patient outcomesreadmissionrisk-predictive algorithms

More Related Videos

Using Human Differentially Expressed Gene Lists to Perform Downstream Pathway Enrichment Analysis and Target Prioritization
03:08

Using Human Differentially Expressed Gene Lists to Perform Downstream Pathway Enrichment Analysis and Target Prioritization

Published on: October 3, 2025

1.1K
A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
12:18

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment

Published on: January 11, 2020

8.2K

Related Experiment Videos

Last Updated: Apr 19, 2026

Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack
07:31

Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack

Published on: May 15, 2020

8.3K
Using Human Differentially Expressed Gene Lists to Perform Downstream Pathway Enrichment Analysis and Target Prioritization
03:08

Using Human Differentially Expressed Gene Lists to Perform Downstream Pathway Enrichment Analysis and Target Prioritization

Published on: October 3, 2025

1.1K
A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
12:18

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment

Published on: January 11, 2020

8.2K

Area of Science:

  • Health Services Research
  • Clinical Pharmacy
  • Predictive Analytics

Background:

  • Optimizing patient outcomes requires effective risk stratification and targeted interventions.
  • Integrating clinical pharmacy data with hospital admission data can enhance predictive modeling.
  • Prioritizing clinical pharmacy services is crucial for improving patient care.

Purpose of the Study:

  • To assess the value of combining clinical pharmacy data and hospital admission data for predictive algorithm development.
  • To identify risk factors and develop targeting strategies for clinical pharmacy services.
  • To optimize patient outcomes through enhanced predictive modeling and service prioritization.

Main Methods:

  • Predictive algorithms were developed using a 75% sample of integrated medicines management (IMM) patients and validated on the remaining 25%.
  • Algorithms utilized factors including previous admissions, admission medications, age-adjusted comorbidity, and diuretic use.
  • Clinical pharmacy staffing levels were correlated with risk-adjusted mortality index (RAMI).

Main Results:

  • Algorithms accurately predicted in-hospital and post-discharge mortality, as well as hospital readmission at 3, 6, and 12 months.
  • Age-adjusted comorbidity was the strongest predictor of mortality.
  • Higher clinical pharmacy staffing levels correlated with a significant reduction in RAMI.

Conclusions:

  • Developed algorithms are valid for predicting patient mortality and readmission risks.
  • Ward-based clinical pharmacy services are essential for reducing RAMI.
  • Effective clinical pharmacy input maximizes patient care benefits and optimizes outcomes.